首页> 外文期刊>Research policy >Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks
【24h】

Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks

机译:1975年以来公司间在制药生物技术领域的研发合作伙伴关系:趋势,模式和网络

获取原文
获取原文并翻译 | 示例
           

摘要

This paper analyses a large, longitudinal database on inter-firm R&D partnerships formed in the high-tech pharmaceutical biotechnology industry since 1975. Our research indicates an overall growth in the number of annually, newly established R&D partnerships where research partners consistently prefer contractual partnerships to equity-based alliances. In the networks that develop through these R&D partnerships, small, entrepreneurial biotechnological companies take a leading role during the 1980s, when biotechnology first became relevant for the pharmaceutical industry. The 1990s, however, show a different pattern with established, large pharmaceutical companies becoming more dominant, acting as nodal players with multiple partnerships with a variety of other companies. (c) 2006 Elsevier B.V. All rights reserved.
机译:本文分析了自1975年以来在高科技制药生物技术行业中形成的企业间R&D合作伙伴关系的大型纵向数据库。我们的研究表明,每年新建的R&D合作伙伴关系的数量总体上有所增长,其中研究合作伙伴始终偏爱合同合作伙伴股权联盟。在通过这些研发合作伙伴关系发展的网络中,小型,具有创业精神的生物技术公司在1980年代(生物技术首次与制药行业相关时)起着领导作用。但是,1990年代却显示出不同的模式,大型的制药公司逐渐占据主导地位,并与其他各种公司建立了多种合作伙伴关系,成为节点公司。 (c)2006 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号